1-8 of 8
autologous stem cell transplant
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Five-year outcomes of the S1106 study of R-hyper-CVAD vs R-bendamustine in transplant-eligible patients with mantle cell lymphoma

Manali Kamdar, Hongli Li, Robert W. Chen, Lisa M. Rimsza, Michael L. Leblanc, Timothy S. Fenske, Thomas C. Shea, Paul M. Barr, Tycel J. Phillips, John P. Leonard, Brad S. Kahl, Jonathan W. Friedberg, Sonali M. Smith
Blood Advances (2019) 3 (20): 3132–3135.
DOI: https://doi.org/10.1182/bloodadvances.2019000526
Published: 2019
Journal Articles

Pathophysiology and management of monoclonal gammopathy of renal significance

Clinical Trials & Observations
Ankur Jain, Richard Haynes, Jaimal Kothari, Akhil Khera, Maria Soares, Karthik Ramasamy
Blood Advances (2019) 3 (15): 2409–2423.
DOI: https://doi.org/10.1182/bloodadvances.2019031914
Published: 2019
Journal Articles

Minimal residual disease negativity in multiple myeloma is associated with intestinal microbiota composition

Clinical Trials & Observations
Matthew J. Pianko, Sean M. Devlin, Eric R. Littmann, Aisara Chansakul, Donna Mastey, Meghan Salcedo, Emily Fontana, Lilan Ling, Elizabet Tavitian, John B. Slingerland, Ann E. Slingerland, Annelie Clurman, Antonio L. C. Gomes, Ying Taur, Eric G. Pamer, Jonathan U. Peled, Marcel R. M. van den Brink, Ola Landgren, Alexander M. Lesokhin
Blood Advances (2019) 3 (13): 2040–2044.
DOI: https://doi.org/10.1182/bloodadvances.2019032276
Published: 2019
Journal Articles

Long‐term safety and activity of NY-ESO‐1 SPEAR T cells after autologous stem cell transplant for myeloma

Clinical Trials & Observations
Edward A. Stadtmauer, Thomas H. Faitg, Daniel E. Lowther, Ashraf Z. Badros, Karen Chagin, Karen Dengel, Malini Iyengar, Luca Melchiori, Jean-Marc Navenot, Elliot Norry, Trupti Trivedi, Ruoxi Wang, Gwendolyn K. Binder, Rafael Amado, Aaron P. Rapoport
Blood Advances (2019) 3 (13): 2022–2034.
DOI: https://doi.org/10.1182/bloodadvances.2019000194
Published: 2019
Journal Articles

CyBorD-DARA is potent initial induction for MM and enhances ADCP: initial results of the 16-BCNI-001/CTRIAL-IE 16-02 study

Clinical Trials & Observations
M. O’Dwyer, R. Henderson, S. D. Naicker, M. R. Cahill, P. Murphy, V. Mykytiv, J. Quinn, C. McEllistrim, J. Krawczyk, J. Walsh, E. Lenihan, T. Kenny, A. Hernando, G. Hirakata, I. Parker, E. Kinsella, G. Gannon, A. Natoni, K. Lynch, A. E. Ryan
Blood Advances (2019) 3 (12): 1815–1825.
DOI: https://doi.org/10.1182/bloodadvances.2019000010
Published: 2019
Journal Articles

Impact of post-ASCT maintenance therapy on outcomes in patients with newly diagnosed multiple myeloma in Connect MM

Clinical Trials & Observations
Sundar Jagannath, Rafat Abonour, Brian G. M. Durie, Mohit Narang, Howard R. Terebelo, Cristina J. Gasparetto, Kathleen Toomey, James W. Hardin, Lynne Wagner, Amit Agarwal, Shankar Srinivasan, Amani Kitali, E. Dawn Flick, Michael Sturniolo, Robert M. Rifkin
Blood Advances (2018) 2 (13): 1608–1615.
DOI: https://doi.org/10.1182/bloodadvances.2018017186
Published: 2018
Includes: Supplemental data
Journal Articles

Prognostic significance of bone marrow abnormalities in the appendicular skeleton of patients with multiple myeloma

Clinical Trials & Observations
Kosei Matsue, Hiroki Kobayashi, Yuya Matsue, Yoshiaki Abe, Kentaro Narita, Akihiro Kitadate, Masami Takeuchi
Blood Advances (2018) 2 (9): 1032–1039.
DOI: https://doi.org/10.1182/bloodadvances.2017014720
Published: 2018
Includes: Supplemental data
Journal Articles

Should all patients with HL who relapse after ASCT be considered for allogeneic SCT? A consult, yes; a transplant, not necessarily

Craig H. Moskowitz
Blood Advances (2018) 2 (7): 821–824.
DOI: https://doi.org/10.1182/bloodadvances.2017011130
Published: 2018